Skip to main content
    G

    Gelteq Limited Ordinary Shares (GELS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.27
    -0.09 (-25.05%)

    Market Cap: $3.84M

    Last updated: Nov 17, 2026 at 4:40 PM ET

    Gelteq Limited Ordinary Shares (GELS) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Gelteq Limited Ordinary Shares (GELS) has a latest price of $0.27 on Nov 17, 2026. Its price fell 73.0% over the past 12 months.

    Price Chart

    From Oct 2024 to Oct 2026, its highest month-end close was $2.56 in Oct 2024 and its lowest $0.49 in May 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart GELS with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GELS.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 51.6%, and over 6 months it fell 31.0%.

    PeriodChange
    1 month-37.5%
    3 months-51.6%
    6 months-31.0%
    12 months-73.0%
    12 months, with dividends-73.0%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$0.49-38.7%
    2025$0.80-65.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 47.3% below its 50-day average of $0.51 and 56.7% below its 200-day average of $0.62.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.27
    50-day average$0.51-47.3%
    200-day average$0.62-56.7%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 94.4%.

    MeasureValue
    1-year beta1.88
    Largest fall, 1 year-82.4%
    Largest fall, 3 years-94.4%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About GELS

    What is GELS's 1-year price change?

    Gelteq Limited Ordinary Shares's price fell 73.0% over the past 12 months. With dividends included, the 12-month total return was -73.0%.

    What is GELS's beta?

    Gelteq Limited Ordinary Shares's 1-year beta against the S&P 500 is 1.88, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 82.4%.

    Is the GELS chart free?

    Yes. Advanced Charting for GELS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.